Capital Performance Advisors’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8,149
Closed -$837K 316
2026
Q1
$837K Sell
8,149
-17
-0.2% -$1.92K 0.06% 149
2025
Q4
$1.02M Buy
8,166
+4,042
+98% +$515K 0.07% 114
2025
Q3
$552K Sell
4,124
-863
-17% -$113K 0.09% 117
2025
Q2
$678K Buy
4,987
+830
+20% +$109K 0.13% 80
2025
Q1
$551K Buy
4,157
+2,020
+95% +$257K 0.12% 92
2024
Q4
$242K Buy
2,137
+269
+14% +$31.1K 0.08% 123
2024
Q3
$213K Buy
+1,868
New +$205K 0.06% 105

Other funds holding ABT

Capital Performance Advisors's ABT Position: Q2 2026 in Review

Capital Performance Advisors sold out of Abbott (ABT) in Q2 2026, closing a stake of 8,149 shares — an estimated $837K sold.

Capital Performance Advisors first reported a position in ABT in Q3 2024 and held it in 7 quarters. The position peaked at $1.02M in Q4 2025. 2,963 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Capital Performance Advisors reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
  • Capital Performance Advisors sold 8,149 Abbott shares in Q2 2026, an estimated $837K.
  • Capital Performance Advisors first reported a position in Abbott in Q3 2024 and held it in 7 quarters.
  • Capital Performance Advisors's Abbott position peaked at $1.02M in Q4 2025.
  • 2,963 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Capital Performance Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.